Search
Search Results
##search.searchResults.foundPlural##
-
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1567PDF: 1411HTML: 123 -
IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA Microelimination Strategy of Chronic Hepatitis C Infection in patients with Hemophilia
1000PDF: 463HTML: 163 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7182PDF: 3814HTML: 847 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2427PDF: 1024HTML: 528Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 269UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 411Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 303Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 225Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 240Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 318 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2075PDF: 878HTML: 2226Table 1: 233Table 2: 248Table 3: 244Table 4: 244Table 5: 242Tble 6: 237Cover Letter: 252Greene Tab.7: 255 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2557HTML: 9434DOCX: 1078Tables Dengue: 264 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4776PDF: 2053HTML: 18215 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
2013PDF: 819HTML: 255 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2810PDF: 1010HTML: 604 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1601PDF: 918HTML: 1121Untitled: 224 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2239PDF: 840HTML: 1094Spirometry in SCA patients before transplant: 258Spirometry in SCA patients post transplant: 227 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
2005PDF: 532HTML: 4052 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2736PDF: 1040HTML: 15146 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1973PDF: 861HTML: 3699 -
-
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1448PDF: 1227HTML: 166 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
3060PDF: 1526HTML: 333 -
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5539PDF: 1422HTML: 2884Cover letter: 250 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
3089PDF: 1093HTML: 191 -
-
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
5276PDF: 2064HTML: 11547Fig 1: 285Fig 2: 236Fig 3: 362Fig 4: 253Fig 5: 253Fig 6: 239Fig 7: 259Fig 8: 242 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1700PDF: 1190HTML: 277 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1777PDF: 1094HTML: 562 -
-
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1889PDF: 572HTML: 365 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3766PDF: 1205HTML: 23385 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3299PDF: 1697HTML: 402 -
-
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1440PDF: 1113HTML: 4678 -
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1910PDF: 670HTML: 495 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1273PDF: 889Html: 210







